|
1.
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
2.
|
Macdonald JS, Smalley SR, Benedetti J, et
al: Chemoradiotherapy after surgery compared with surgery alone for
adenocarcinoma of the stomach or gastroesophageal junction. N Engl
J Med. 345:725–730. 2001. View Article : Google Scholar
|
|
3.
|
Lehnert T, Rudek B, Buhl K, et al:
Surgical therapy for loco-regional recurrence and distant
metastasis of gastric cancer. Eur J Surg Oncol. 28:455–461. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Zhang X, Yan Z, Zhang J, et al:
Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for
recurrence risk in gastric cancer patients following surgical
resection. Ann Oncol. 22:2257–2266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Roukos DH and Kappas AM: Limitations in
controlling risk for recurrence after curative surgery for advanced
gastric cancer are now well-explained by molecular-based
mechanisms. Ann Surg Oncol. 8:620–621. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Fondevila C, Metges JP, Fuster J, et al:
p53 and VEGF expression are independent predictors of tumour
recurrence and survival following curative resection of gastric
cancer. Br J Cancer. 90:206–215. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Marrelli D, De Stefano A, de Manzoni G, et
al: Prediction of recurrence after radical surgery for gastric
cancer a scoring system obtained from a prospective multicenter
study. Ann Surg. 241:247–255. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Inoue H, Matsuyama A, Mimori K, et al:
Prognostic score of gastric cancer determined by cDNA microarray.
Clin Cancer Res. 8:3475–3479. 2002.PubMed/NCBI
|
|
9.
|
Motoori M, Takemasa I and Yano M:
Prediction of recurrence in advanced gastric cancer patients after
curative resection by gene expression profiling. Int J Cancer.
114:963–968. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Sim SH, Kim YJ, Oh DY, et al: The role of
PET/CT in detection of gastric cancer recurrence. BMC Cancer.
9:732009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Patterson TA, Lobenhofer EK,
Fulmer-Smentek SB, et al: Performance comparison of one-color and
two-color platforms within the MicroArray Quality Control (MAQC)
project. Nat Biotechnol. 24:1140–1150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Tusher VG, Tibshirani R and Chu G:
Significance analysis of microarrays applied to transcriptional
responses to ionizing radiation. Proc Natl Acad Sci USA.
98:5116–5121. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Tibshirani RJ, Hastie TJ, Narasimhan B, et
al: Diagnosis of multiple cancer types by shrunken centroids of
gene expression. Proc Natl Acad Sci USA. 99:6567–6572. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Guyon I, Weston J, Barnhill S, et al: Gene
selection for cancer classification using support vector machines.
Machine Learning. 46:389–422. 2002. View Article : Google Scholar
|
|
15.
|
Furey TS, Cristianini N, Duffy N, et al:
Support vector machines classification and validation of cancer
tissue samples using microarray expression data. Bioinformatics.
16:906–914. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Chen X and Ishwaran H: Random forests for
genomic data analysis. Genomics. 99:323–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Li S, Harner EJ and Adjeroh DA: Random KNN
feature selection - a fast and stable alternative to Random
Forests. BMC Bioinformatics. 12:4502011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yan Z, Li J, Xiong Y, et al:
Identification of candidate colon cancer biomarkers by applying a
random forest approach on microarray data. Oncol Rep. 28:1036–1042.
2012.PubMed/NCBI
|
|
19.
|
Kenneth JL and Thomas DS: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001.
|
|
20.
|
Tang F, Zhang R, He Y, et al:
MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and
MDA-MB-231 breast cancer cells. PLoS One. 7:e354352012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Gregersen LH, Jacobsen A, Frankel LB, et
al: microRNA-143 down-regulates Hexokinase 2 in colon cancer cells.
BMC Cancer. 12:2322012. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Dey N, Das F, Ghosh-Choudhury N, et al:
microRNA-21 governs TORC1 activation in renal cancer cell
proliferation and invasion. PLoS One. 7:e373662012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Kumar B, Yadav A, Lang J, et al:
Dysregulation of microRNA-34a expression in head and neck squamous
cell carcinoma promotes tumor growth and tumor angiogenesis. PLoS
One. 7:e376012012. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Poy MN, Eliasson L, Krutzfeldt J, et al: A
pancreatic islet-specific microRNA regulates insulin secretion.
Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Chen CZ, Li L, Lodish HF, et al: MicroRNAs
modulate hematopoietic lineage differentiation. Science. 303:83–86.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Liang RQ, Li W, Li Y, et al: An
oligonucleotide microarray for microRNA expression analysis based
on labeling RNA with quantum dot and nanogold probe. Nucl Acids
Res. 33:e172005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ralfkiaer U, Hagedorn PH, Bangsgaard N, et
al: Diagnostic microRNA profiling in cutaneous T-cell lymphoma
(CTCL). Blood. 118:5891–5900. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Yan Z, Xiong Y, Xu W, et al:
Identification of hsa-miR-335 as a prognostic signature in gastric
cancer. PLoS One. 7:e400372012. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Augello C, Vaira V, Caruso L, et al:
MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster
as a novel prognostic biomarker in hepatocellular carcinoma. Liver
Int. 32:772–782. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Ferracin M, Pedriali M, Veronese A, et al:
MicroRNA profiling for the identification of cancers with unknown
primary tissue-of-origin. J Pathol. 225:43–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Lu Y, Govindan R, Wang L, et al: MicroRNA
profiling and prediction of recurrence/relapse-free survival in
stage I lung cancer. Carcinogenesis. 33:1046–1054. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Liu R, Chen X, Du Y, et al: Serum microRNA
expression profile as a biomarker in the diagnosis and prognosis of
pancreatic cancer. Clin Chem. 58:610–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
White NM, Khella HW, Grigull J, et al:
miRNA profiling in metastatic renal cell carcinoma reveals a
tumour-suppressor effect for miR-215. Br J Cancer. 105:1741–1749.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Yang XH and Huang S: PFM1 (PRDM4), a new
member of the PR-domain family, maps to a tumor suppressor locus on
human chromosome 12q23–q24.1. Genomics. 61:319–325. 1999.PubMed/NCBI
|
